PharmaCyte Biotech Inc PMCB
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2003-09-11 |
| Shares Out. | 10,740,000 |
| Website | pharmacyte.com/ ↗ |
| Phone | 19175952850 |
| Employees | 2 |
| Net Income | -$16.4M |
| Total Assets | $46.8M |
| Total Liabilities | $11.8M |
| Equity | $34.6M |
About PharmaCyte Biotech Inc
PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.
PharmaCyte Biotech Inc is a publicly traded company under the ticker symbol PMCB on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
6 analysts (2023-02-01)